These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20623223)

  • 1. Brushite stone disease as a consequence of lithotripsy?
    Krambeck AE; Handa SE; Evan AP; Lingeman JE
    Urol Res; 2010 Aug; 38(4):293-9. PubMed ID: 20623223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of the brushite stone former.
    Krambeck AE; Handa SE; Evan AP; Lingeman JE
    J Urol; 2010 Oct; 184(4):1367-71. PubMed ID: 20719342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragility of brushite stones in shock wave lithotripsy: absence of correlation with computerized tomography visible structure.
    Williams JC; Hameed T; Jackson ME; Aftab S; Gambaro A; Pishchalnikov YA; Lingeman JE; McAteer JA
    J Urol; 2012 Sep; 188(3):996-1001. PubMed ID: 22819106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones.
    Parks JH; Worcester EM; Coe FL; Evan AP; Lingeman JE
    Kidney Int; 2004 Aug; 66(2):777-85. PubMed ID: 15253733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time.
    Parks JH; Coe FL; Evan AP; Worcester EM
    Nephrol Dial Transplant; 2009 Jan; 24(1):130-6. PubMed ID: 18662977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to improve lithotripsy and chemolitholysis of brushite-stones: an in vitro study.
    Heimbach D; Jacobs D; Hesse A; Müller SC; Zhong P; Preminger GM
    Urol Res; 1999 Aug; 27(4):266-71. PubMed ID: 10460897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Chronic Kidney Disease in Brushite Stone Formers Compared With Idiopathic Calcium Oxalate Stone Formers.
    Rivera M; Jaeger C; Yelfimov D; Krambeck AE
    Urology; 2017 Jan; 99():23-26. PubMed ID: 27634734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in 24-hour urine composition between apatite and brushite stone formers.
    Moreira DM; Friedlander JI; Hartman C; Elsamra SE; Smith AD; Okeke Z
    Urology; 2013 Oct; 82(4):768-72. PubMed ID: 23791217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ureteral stones: SWL treatment.
    Zanetti G
    Arch Ital Urol Androl; 2011 Mar; 83(1):10-3. PubMed ID: 21585162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of synchronous twin pulse technique for shock wave lithotripsy: determination of optimal parameters for in vitro stone fragmentation.
    Sheir KZ; Zabihi N; Lee D; Teichman JM; Rehman J; Sundaram CP; Heimbach D; Hesse A; Delvecchio F; Zhong P; Preminger GM; Clayman RV
    J Urol; 2003 Dec; 170(6 Pt 1):2190-4. PubMed ID: 14634376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of chemical and radiographic factors on the treatment of renal lithiasis using extracorporeal external shock-wave lithotripsy].
    Tobelem G; Economou C; Thomas J; Arvis G
    Ann Urol (Paris); 1987; 21(5):362-7. PubMed ID: 3426165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of differing stone fragility in extracorporeal shockwave lithotripsy.
    Zhong P; Preminger GM
    J Endourol; 1994 Aug; 8(4):263-8. PubMed ID: 7981735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidation of factors determining formation of calcium phosphate stones.
    Pak CY; Adams-Huet B
    J Urol; 2004 Dec; 172(6 Pt 1):2267-70. PubMed ID: 15538246
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Saw JJ; Sivaguru M; Wilson EM; Dong Y; Sanford RA; Fields CJ; Cregger MA; Merkel AC; Bruce WJ; Weber JR; Lieske JC; Krambeck AE; Rivera ME; Large T; Lange D; Bhattacharjee AS; Romero MF; Chia N; Fouke BW
    Kidney360; 2021 Feb; 2(2):298-311. PubMed ID: 35373025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stone fragility: its therapeutic implications in shock wave lithotripsy of upper urinary tract stones.
    Ansari MS; Gupta NP; Seth A; Hemal AK; Dogra PN; Singh TP
    Int Urol Nephrol; 2003; 35(3):387-92. PubMed ID: 15160546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of renal papillae in kidney stone formers.
    Marien TP; Miller NL
    Minerva Urol Nefrol; 2016 Dec; 68(6):496-515. PubMed ID: 27441596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual roles of brushite crystals in calcium oxalate crystallization provide physicochemical mechanisms underlying renal stone formation.
    Tang R; Nancollas GH; Giocondi JL; Hoyer JR; Orme CA
    Kidney Int; 2006 Jul; 70(1):71-8. PubMed ID: 16641926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones.
    Evan AP; Lingeman JE; Worcester EM; Sommer AJ; Phillips CL; Williams JC; Coe FL
    Anat Rec (Hoboken); 2014 Apr; 297(4):731-48. PubMed ID: 24478243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.